Patent Assignment
Reel/Frame 048388/0406
Assignment of Assignor's Interest
Recorded: 2019-02-20
Pages: 3
Assignor
UCB MANUFACTURING IRELAND LIMITED
Executed: 2019-02-19
Assignee
UCB BIOPHARMA SPRL
ALLEE DE LA RECHERCHE 60, BRUSSELS, 1070, BELGIUM
Covered Property
(1)
Method for Producing a Transdermal Therapeutic System Which Contains a D2 Agonist
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 20, 2005
From: ADERIS PHARMACEUTICALS, INC.
To: SCHWARZ PHARMA LIMITED
Reel/Frame 016283/0716 →
Change of Name
Feb 27, 2012
From: MULLER, WALTER; PECK, JAMES V.
To: LTS LOHMANN THERAPIE-SYSTEME AG; DISCOVERY THERAPEUTICS, INC.
Reel/Frame 027769/0321 →
Change of Name
Feb 27, 2012
From: DISCOVERY THERAPEUTICS, INC.
To: ADERIS PHARMACEUTICALS, INC.
Reel/Frame 027770/0865 →
Change of Name
Feb 27, 2012
From: SCHWARZ PHARMA LIMITED
To: UCB MANUFACTURING IRELAND LIMITED
Reel/Frame 027770/0880 →
Corrective Assignment to Correct the Nature of Conveyance from Change of Name to Assignment Previously Recorded on Reel 027769 Frame 0321. Assignor(S) Hereby Confirms the Change of Name.
Mar 1, 2012
From: MULLER, WALTER; PECK, JAMES V
To: LTS LOHMANN THERAPIE-SYSTEME AG; DISCOVERY THERAPEUTICS, INC.
Reel/Frame 027793/0328 →